Thanks Havelots, I know you and adreamer already know this stuff but thought it important to bring to the fore for those who maybe not aware.
From here : https://investorhub.pharmaust.com/announcements/6212289
Prof Leonard van den Berg commented:
“I’m very excited to be a part of PharmAust’s SAB and look forward to guiding with my fellow SAB members the
next phase of clinical development of monepantel for the treatment of MND/ALS. There is a clear need for more
effective treatment options for MND/ALS. The survival data produced to date with monepantel is encouraging and
compounds that enhance autophagy have the potential to treat a wide range of neurodegenerative diseases”.
The same Prof Leonard van den Berg that is the chair of TRICALS.
Thanks Havelots, I know you and adreamer already know this stuff...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.005(2.44%) |
Mkt cap ! $83.14M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 21.0¢ | $262.8K | 1.225M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25394 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 44560 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |